Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 23, 2005
[Radiotherapy for PSA failure after prostatectomy: which volumes?]M Bosset, P Maingon, J F Bosset
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 15, 2006
[What to do with a rising PSA after complete remission post-prostatectomy?]M Bosset, J-F Bosset, P Maingon
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 18, 2003
[Cancer of the rectum: target volumes for preoperative radiotherapy]F Lorchel, P Maingon, G Crehange, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 13, 2005
[Conformal radiation therapy with or without intensity modulation in the treatment of localized prostate cancer]P Maingon, M Bolla, G Truc, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 28, 2007
[Preoperative treatments of rectal cancers]J-F Bosset, F Nguyen, M Bosset, et al.
Journal of Surgical Oncology|November 22, 2005
Radiation and chemoradiation therapy for esophageal adenocarcinomaJean-François Bosset, F Lorchel, G Mantion, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 27, 2021
[Low dose radiotherapy for COVID-19 pneumopathy: Biological rationale and literature review]C Miran, É Bonnet, B Allignet, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 22, 2022
[Radiation induced brachial plexopathy: Diagnosis, risk factors, principles of care]C Miran, E Bonnet, C Lafont, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 25, 2015
[Interobserver variability study for daily cone beam computed tomography registration of prostate volumetric modulated arc therapy]N Zahra, C Monnet, E Bartha, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 27, 2021
A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patientsN Khalladi, C Dejean, M Bosset, et al.
Pageof 1